Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions. - Wikidata - wikimedia - TriplyDB

Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions.

Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions.

http://www.wikidata.org/entity/Q37909365

about

Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer.Biological intensity-modulated radiotherapy plus neoadjuvant chemotherapy for multiple peritoneal metastases of ovarian cancer: A case report.Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer.Clinical trials of neoadjuvant chemotherapy for ovarian cancer: what do we gain after an EORTC trial and after two additional ongoing trials are completed?The number of cycles of neoadjuvant chemotherapy is associated with prognosis of stage IIIc-IV high-grade serous ovarian cancer.Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer.Positive peritoneal cytology at interval surgery is a poor prognostic factor in patients with stage T3c advanced ovarian carcinoma: A retrospective study.Review of methodological challenges in comparing the effectiveness of neoadjuvant chemotherapy versus primary debulking surgery for advanced ovarian cancer in the United States

P2860

Q24201686-88817DCE-9267-4CD5-8DAA-50440F9744AA Q33873793-C970FB82-CCF4-44FC-8521-99B861598FB2 Q35042000-D1DF7AE1-A411-4444-832B-AC56956316FE Q37466140-BE7BA175-8466-40EA-84D9-0391224AFC70 Q38090546-75066220-E14B-47DC-8054-F0262D48BFEC Q40443819-3EBF10A0-32DF-4119-9774-955D23487986 Q47156509-9B231BD5-3380-4070-B83D-FCFA599AD005 Q53081124-1108C706-549B-42A4-9CA3-72CD3E87D8EB Q57171698-12468EA4-A67E-466A-8552-CC65B576C2B8

P2860

Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions.

http://www.wikidata.org/entity/Q37909365

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Neoadjuvant chemotherapy for a ...... omes and unanswered questions.

@en

Neoadjuvant chemotherapy for a ...... omes and unanswered questions.

@nl

type

label

Neoadjuvant chemotherapy for a ...... omes and unanswered questions.

@en

Neoadjuvant chemotherapy for a ...... omes and unanswered questions.

@nl

prefLabel

Neoadjuvant chemotherapy for a ...... omes and unanswered questions.

@en

Neoadjuvant chemotherapy for a ...... omes and unanswered questions.

@nl

P1433

Q37909365-E5334E19-2312-4BE8-B665-7C95A4FAC7D5

P1476

Q37909365-5BCEF292-5D5D-4815-8C8B-1530FB7FD2BA

P2093

Q37909365-965064C5-F7F1-44D7-AEB3-3EFB0F8DD1B8

Q37909365-9A6F16E0-6136-40AC-B936-9AF813178368

P2860

Q37909365-038255D6-14AE-41C4-89A9-5D0CCFF44A80

Q37909365-0DEF09E4-4590-46FC-9FC3-FA52A0C631F7

Q37909365-162B6A63-5C4A-41B9-BE01-143B95E4F08B

Q37909365-1860C698-B9E8-4976-8CDE-FCEC738EC794

Q37909365-1AA8FE7C-3CAC-4EAB-814B-DD4BD841FC95

Q37909365-25BBB48E-A727-46BB-B683-DD287D774FE5

Q37909365-3D48AAEC-C7DD-40D7-B4FE-1213836170D6

Q37909365-4AD56887-1939-4C4F-A864-32BCB2E3F16E

Q37909365-53ADB4FA-1F36-4AFB-ADF1-D25C6EDE0B2A

Q37909365-55711524-9CCD-4669-8A7B-40A25FB2F871

P304

Q37909365-74400664-0F51-48AA-8003-014425A1DA43

P31

Q37909365-24BAACB7-24F1-46E7-905E-C00506F8D008

P356

Q37909365-4200FD99-C72A-4BC9-B1BD-233A840078B4

P433

Q37909365-33CC2826-5AAB-4AED-B56B-3F735112C5CA

P478

Q37909365-7FA920E2-0FFE-4153-9D5A-844A033A5BD8

P577

Q37909365-924EF665-2D99-4C55-BDA1-E3D3B8537612

P5875

Q37909365-C987C6E2-BDF0-40E6-B09C-14D8CE71173D

P698

Q37909365-03DD2DF5-6010-4056-A524-8600AFAA1BE5

P921

Q37909365-25F85A97-F3CD-405F-9E89-057DC618163D

Q37909365-6C367C6D-88F8-4EC2-ABE9-2E387D2B68A1

P356

P1433

Expert Review of Anticancer Therapy

P1476

Neoadjuvant chemotherapy for a ...... omes and unanswered questions.

@en

P2093

Hiroyuki Yoshikawa

http://www.w3.org/2001/XMLSchema#string

Takashi Onda

http://www.w3.org/2001/XMLSchema#string

P2860

Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma.

Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer.

Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer: a retrospective study of 574 patients.

Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses.

Cytoreductive surgery for advanced stages of ovarian cancer.

Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer.

Neoadjuvant chemotherapy for advanced ovarian cancer: the role of cytology in pretreatment diagnosis.

Primary chemotherapy and adjuvant tumor debulking in the management of advanced-stage epithelial ovarian cancer.

Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009.

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

P304

1053-1067

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERA.11.24

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51537570

http://www.w3.org/2001/XMLSchema#string

P698

21806329

http://www.w3.org/2001/XMLSchema#string

P921